Get started
Author

Myria Galazi

Observed names: Galazi, Myria, M. Galazi
Observed institutions: National Health Service, University College Hospital, Guy's Hospital, St Bartholomew's Hospital, University College London Hospitals NHS Foundation Trust, Imperial College Healthcare NHS Trust, King's College London, Guy's and St Thomas' NHS Foundation Trust, Barts Health NHS Trust, Luton and Dunstable University Hospital NHS Foundation Trust, Hammersmith Hospital, Institut Gustave Roussy, Luton and Dunstable Hospital, Charing Cross Hospital, Institut Català d'Oncologia, Chelsea and Westminster Hospital, Bank of Cyprus Oncology Center, Barts Cancer Institute, University College London, Imperial College London
ORCID: 0000-0002-1933-2414
Observed ORCID: 0000-0002-1933-2414
OpenAlex ID: A5003203912
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
2020 · Lennard Y W Lee, Jean-Baptiste Cazier, et al. · The Lancet Oncology · 590
PDF
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
2020 · David J. Pinato, Alberto Zambelli, et al. · Cancer Discovery · 184
PDF
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
2021 · David J Pinato, Josep Tabernero, et al. · The Lancet Oncology · 134
PDF
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
2022 · David J Pinato, Daniela Ferrante, et al. · The Lancet Oncology · 81
PDF
Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
2015 · Alejo Rodriguez-Vida, Simon Chowdhury, et al. · Drug Design Development and Therapy · 70
PDF
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19
2022 · Csilla Várnai, Claire Palles, et al. · JAMA Network Open · 62
PDF
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
2020 · David J. Pinato, Alvin J. X. Lee, et al. · Cancers · 61
PDF
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
2021 · David J. Pinato, Lorenza Scotti, et al. · European Journal of Cancer · 49
PDF
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer
2016 · Edward Johnston, Hayley Pye, et al. · BMC Cancer · 49
PDF
d -Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review
2010 · Nicolas Galazis, Myria Galazi, et al. · Gynecological Endocrinology · 48
c-Met PET Imaging Detects Early-Stage Locoregional Recurrence of Basal-Like Breast Cancer
2015 · Appitha Arulappu, Mark Battle, et al. · Journal of Nuclear Medicine · 35
PDF
Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration
2013 · Nicolas Galazis, Yik-Lam Pang, et al. · Gynecological Endocrinology · 27
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review
2023 · Alexia Alexandraki, Elisavet Papageorgiou, et al. · Cancers · 24
PDF
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
2023 · Caitlin R. Davies, Tianyu Guo, et al. · Frontiers in Oncology · 20
Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience
2020 · Christopher C. T. Sng, Yien Ning Sophia Wong, et al. · Frontiers in Oncology · 19
PDF
Precision medicine for prostate cancer
2014 · Myria Galazi, Alejo Rodriguez-Vida, et al. · Expert Review of Anticancer Therapy · 17
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole–body magnetic resonance imaging in radio-recurrent prostate cancer
2019 · Sola Adeleke, Arash Latifoltojar, et al. · BMC Medical Imaging · 15
PDF
HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models
2022 · Valentí Gómez, Myria Galazi, et al. · Molecular Cancer Therapeutics · 12
PDF
318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
2020 · D.J. Pinato, A. Zambelli, et al. · Annals of Oncology · 12
PDF
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
2021 · Laia Garrigós, Cristina Saura, et al. · Therapeutic Advances in Medical Oncology · 8
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
2021 · Gehan Soosaipillai, Anjui Wu, et al. · Therapeutic Advances in Medical Oncology · 7
The role of metastasectomy in renal cell carcinoma
2013 · Eleni Josephides, Alejo Rodriguez-Vida, et al. · Expert Review of Anticancer Therapy · 6
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development
2022 · Paul R Barber, Rami Mustapha, et al. · eLife · 5
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital
2021 · Yien Ning Sophia Wong, Christopher C. T. Sng, et al. · Cancers · 4
PDF
Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen
2020 · Ernese Gjafa, Kenrick Ng, et al. · British Journal of Urology · 4
Works count: 75
Citation count: 1,564
H-index: 16
I10-index: 19
Year
Topic
Type